Researchers from the Centre for Gene Therapy & Regenerative Medicine at King’s College London, in collaboration with colleagues from University College London, have developed the first truly scalable human iPSC-neuromuscular disease model.
Researchers from the Centre for Gene Therapy & Regenerative Medicine at King’s College London, in collaboration with colleagues from University College London, have developed the first truly scalable human iPSC-neuromuscular disease model.
Leave A Comment